

Lead Product(s) : Talaporfin
Therapeutic Area : Urology
Study Phase : Phase II
Sponsor : Mundipharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Talaporfin sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Prostatic Hyperplasia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 29, 2014
Lead Product(s) : Talaporfin
Therapeutic Area : Urology
Highest Development Status : Phase II
Sponsor : Mundipharma
Deal Size : Inapplicable
Deal Type : Inapplicable


 
															 Reset All
Reset All